Details of HTA project
Last updated: 9 October 2008 - Next update due: 14 October 2008
Research type: |
NICE Technology Assessment Report (TAR) |
Project title: |
The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults |
Link to NICE guidance page |
|
Project ref: |
06/59/01 |
Cost: |
This project has been commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis. |
Chief Investigator : |
Peninsula Medical School (PenTAG), University of Exeter |
Start Date: |
November 2006. |
Publication date: |
April 2009. This project is at the editorial review stage. Delays in the review process can cause the forecast publication date to be delayed. |
Plain English Summary |
This project will review the evidence for the use of cochlear implants for children and adults who have severe or profound deafness. A cochlear implant is an electronic device, with internal and external parts, in which the hearing part of the brain is stimulated by electrodes placed in the inner ear. This gives a sensation of hearing which can be used to interpret sounds, thus aiding communication. The assessment will look at devices used in one or both ears and will draw together all the relevant evidence about cochlear implants systematically. It will also assess whether this treatment is likely to be considered good value for money for the NHS. |
Abstract: |
The purpose of this technology assessment is to appraise the clinical and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults. Since cochlear implants may be placed in either one or both ears, and because having one cochlear implant may be an intermediate step between having none and having two, there are in fact two decision problems: (1) should people without a cochlear implant have one implanted, and (2) should people already with one (unilateral) cochlear implant receive a second one in their other ear (i.e. 'bilateral cochlear implantation'). More fully therefore, the policy questions to be answered are: 1.For severely or profoundly deaf people (who may be either using or not using hearing aids), is it effective and cost-effective to implant a first (i.e. unilateral) cochlear implant? 2.For severely or profoundly deaf people with a single cochlear implant (either unilateral or unilateral with a hearing aid, is it effective and cost-effective to implant a second (i.e. bilateral) cochlear implant? It is expected that the outcome measures will vary according to the adult and child populations. If possible outcome measures will include: -Audiological outcomes (e.g. sound perception, speech recognition, sound localisation) -Language and communication outcomes (e.g. intelligibility, sentence comprehension) -Psychosocial development/adjustment -Adverse effects of treatment -Health-related quality of life -Cost and cost-effectiveness (if possible, as a cost-utility analysis) -Educational outcomes (e.g. achievement, school placement) THE HTA PROGRAMME COMMISSIONED THIS TECHNOLOGY ASSESSMENT REPORT ON BEHALF OF THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. |
MeSH* index primary terms: |
DEAFNESS Q-therapy; DEAFNESS Q-economics; COCHLEAR-IMPLANTS Q-economics |
MeSH* index secondary terms: |
HUMANS; COST-BENEFIT-ANALYSIS; CHILD; ADULT |
NRR* number, if applicable: |
N0484189157 (*National Research Register) |
Project Protocol: |
Project protocol not available |
URL of this page: |
http://www.hta.ac.uk/1593 |
News feeds